Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy
- 8 June 2017
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 31 (14) , 1865-1872
Abstract
Biological factors are known to influence the fetal fraction (FF) of cell-free DNA and may also influence the accuracy of non-invasive prenatal testing. NIPT from 5267 mixed risk women across three specialist clinics in Australia were analyzed. Multivariable regression analysis was used to determine whether maternal characteristics, ultrasound, and placental biomarkers affect FF and test accuracy. FF ranged from 4% to 37% (mean 11.6%). Body mass index (BMI), gestation, and placental biomarkers were found to be significant factors associated with FF. For each unit increase in BMI, the logarithmically transformed FF, (lnFF), mean value decreased by 0.027. Each week increases in gestation, lnFF increased by 0.023. Each unit increase in free BhCG, PAPPA, and PlGF, the lnFF increased by 0.065, 0.050, and 0.17, respectively. There was no significant association between FF with either maternal age or nuchal translucency. The false-positive cases and one false-negative case did not have lower FF than the true-positive cases. The fetal fraction in maternal plasma cfDNA increased with gestational age, serum pregnancy-associated plasma protein A (PAPP-A), β-hCG, and PlGF and decreased with increasing maternal BMI. There was no significant correlation between low FF and test accuracy, when FF was above 4%.Keywords
This publication has 28 references indexed in Scilit:
- Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth RestrictionPLOS ONE, 2012
- Fetal Fraction in Maternal Plasma Cell-Free DNA at 11–13 Weeks’ Gestation: Effect of Maternal and Fetal FactorsFetal Diagnosis and Therapy, 2012
- DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation studyGenetics in Medicine, 2011
- Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal BloodClinical Chemistry, 2011
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical settingAmerican Journal of Obstetrics and Gynecology, 2011
- The Quest for Accurate Measurement of Fetal DNA in Maternal PlasmaClinical Chemistry, 2011
- Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studiesUltrasound in Obstetrics & Gynecology, 2010
- Pregnancy outcome in the setting of extremely low first trimester PAPP‐A levelsAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2009
- Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal DNA in Maternal PlasmaClinical Chemistry, 2008
- Three-dimensional Ultrasound Measurement of the Placental Volume in Early Pregnancy: Method and Correlation with Biochemical Placenta ParametersPlacenta, 2001